HIGHLIGHTS
- who: Saki Sultana and colleagues from the Department of Anesthesia, Management and Perioperative Medicine, Dalhousie University, Halifax, NS B H , Canada have published the paper: Components of the Endogenous Cannabinoid System as Potential Biomarkers for Interstitial Cystitis/Bladder Pain Syndrome, in the Journal: Diagnostics 2022, 12, 19. of 23/Dec/2021
- what: As studies have shown strong links between the ECS and bladder function both in normal and pathological conditions, there is a strong possibility that components of the ECS, especially the endocannabinoid ligands, fatty_acid amides, and CB2R, can serve as biomarkers for IC/BPS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.